Status:
COMPLETED
A Growth and Hypoallergenicity Study of a New Formula for Infants With Cow Milk Allergy
Lead Sponsor:
Nutricia North America
Collaborating Sponsors:
Nutricia Liverpool
Danone Institute International
Conditions:
Cow Milk Allergy
Eligibility:
All Genders
1-8 years
Phase:
NA
Brief Summary
This study involves the use of 2 different Neocate formulas: a control formula called Neocate Infant and a test Neocate formula. These kinds of formulas are for use in children from birth to 8 months ...
Detailed Description
Infants who qualify will begin a 7-day milk protein elimination diet that excludes all milk or products which contain milk. Parents will be asked to keep a food diary of everything the child eats duri...
Eligibility Criteria
Inclusion
- Subjects aged from birth to 8 months old with documented allergy to cow milk protein are eligible to enter the study. Subjects with other IgE or non IgE mediated allergies to food in addition to milk protein (e.g. multiple food allergy or an eosinophilic disorder) are also eligible to enter the study. However all subjects must have a confirmed allergy to milk confirmed by one of the following criteria, within two months prior to the baseline visit:
- Positive double-blind placebo controlled food challenge with cow milk
- A confirmed history of acute severe reaction after isolated accidental ingestion with a positive test result for IgE antibody
- Confirmed history of a reaction to cow milk protein with CM-specific IgE of \>15kU/L for children over two years and \> 5kU/L for children under two years.
- Confirmed clinical history of a reaction to cow milk protein with a positive skin prick test with a resulting wheal diameter greater or equal to 3mm.
- No confirmed clinical history of a reaction to cow milk protein subjects with a positive skin prick test with a resulting wheal diameter greater or equal to 8mm for children over 2 years and greater or equal to 6mm for children under 2 years.
- For children with an Allergic Eosinophilic Gastroenteritis (AEG), documentation of eosinophilic infiltration and resolution of symptoms on a diet that restricted cow milk (and other foods) with reoccurrence after re-administration of cow milk.
- Written informed consent / ability to give informed consent.
- These subjects are expected to consume a minimum intake of test formula to ensure an average daily intake, which provides at least 50% of their daily energy requirements,
Exclusion
- All subjects
- Infants \<5lb 8oz at birth
- Infants \< 37 weeks gestation
- Infants with severe concurrent illness or major congenital malformations
- Suspected or documented systemic or congenital infections (e.g. human immunodeficiency virus)
- Unable to adhere to protocol instructions due to non compliance of parent or caregiver
- Investigator's uncertainty about the willingness or ability of the patient to comply with the protocol requirements
- Participation in any other studies involving investigational products concomitantly or within twenty eight days prior to entry into the study
- An infant of any personnel connected with the study
- Infants whose parent/caregiver is younger than the legal age of consent
- For these subjects the dietary consumption of other sources of prebiotics or probiotics is prohibited two weeks prior to inclusion in the study and during the study period.
- These subjects must not have received systemic antibiotics in the previous two weeks prior to entry into the study.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00664768
Start Date
March 1 2008
End Date
July 1 2012
Last Update
December 9 2020
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Pendleton Pediatrics
Chandler, Arizona, United States, 85224
2
Visions Clinical Research - Tucson
Tucson, Arizona, United States, 85712
3
Children's Investigational Research Program, LLC (CHIRP)
Bentonville, Arkansas, United States, 72712
4
Children's Hospital, LA
Los Angeles, California, United States, 90027